D.J.Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.70 Cr
as on 31-07-2024
- Paid Up Capital ₹ 1.56 Cr
as on 31-07-2024
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.25 Cr
as on 31-07-2024
- Satisfied Charges ₹ 10.01 Cr
as on 31-07-2024
- Revenue -37.85%
(FY 2023)
- Profit -2.49%
(FY 2023)
- Ebitda 498.69%
(FY 2023)
- Net Worth 23.41%
(FY 2023)
- Total Assets 11.15%
(FY 2023)
About D.J.Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 1.56 Cr.
The company currently has active open charges totaling ₹5.25 Cr. The company has closed loans amounting to ₹10.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shobha Jaiswal and Harshil Jindal serve as directors at the Company.
- CIN/LLPIN
U24232MP1999PTC013611
- Company No.
013611
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Pithampur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at D.J.Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shobha Jaiswal  | Whole-Time Director | 24-May-2016 | Current |
| Harshil Jindal | Director | 07-Dec-2020 | Current |
Financial Performance of D.J.Laboratories.
D.J.Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.85% decrease. The company also saw a slight decrease in profitability, with a 2.49% decrease in profit. The company's net worth Soared by an impressive increase of 23.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D.J.Laboratories?
In 2023, D.J.Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 30 Nov 2023 | ₹3.00 M | Open |
State Bank Of India Creation Date: 16 Feb 2022 | ₹4.95 Cr | Open |
Others Creation Date: 30 Jul 2020 | ₹5.65 M | Satisfied |
How Many Employees Work at D.J.Laboratories?
Unlock and access historical data on people associated with D.J.Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D.J.Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D.J.Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
